Role of epithelial to mesenchymal transition in hepatocellular carcinoma
Gianluigi Giannelli(Gastroenterology Hospital "Saverio de Bellis"), Wolfgang Mikulits(Comprehensive Cancer Center Vienna)
Cited by 641
Related Papers
Targeting transforming growth factor (TGF)‐βRI inhibits activation of β1 integrin and blocks vascular invasion in hepatocellular carcinoma†
|Hepatology|2008|140
Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin‐332/α3 integrin axis recovery of focal adhesion kinase ubiquitination
|Hepatology|2016|102
Laminin-5 stimulates hepatocellular carcinoma growth through a different function of α6β4 and α3β1 integrins
|Hepatology|2007|71
Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis
|Cell Death and Differentiation|2020|68